Skip to main content
Fig. 3 | BMC Ophthalmology

Fig. 3

From: Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes

Fig. 3

Right fundus of a 61-year-old woman in the anti-VEGF group. Baseline BCVA of 20/2000, -16 D. This patient had a total of 3 anti-VEGF injections and a final BCVA of 20/2000. (A) Baseline retinography of CNV diagnosed; (B) 12 months after treatment, macular atrophy developed around the regressed CNV; (C) 24 months after treatment, patchy atrophy arose around the macula

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us